An e-newsletter that focuses on symptom management and treatment updates for NHL and HL and discusses fatigue, infectious complications, and hypersensitivity in these patients.
Release Date: April 2011
CE Available Until: April 30, 2012
Supported by an educational grant from Celgene Corporation |
|
Intended Audience
This continuing education activity is designed for oncology nurses and nurse practitioners, as well as other health care professionals interested in the care of elderly patients with non-Hodgkin and Hodgkin Lymphomas.
Learning Objectives
At the completion of this activity, participants should be better able to
- Discuss recent treatment updates for NHL and HL
- Describe management strategies for NHL and HL patients experiencing each of the following: fatigue, infectious complications, and hypersensitivity reactions
Rationale and Purpose
This activity—designed as a series of 4 e-newsletters—presents the latest developments in the care of older adults with hematologic malignancies to facilitate state-of-the-art medical and nursing care. Promoting evidenced-based practice guidelines will improve integration of new therapies into clinical practice, thereby affecting patient outcomes and enhancing quality of life. This third e-newsletter focuses on symptom management and treatment updates for NHL and Hl and discusses fatigue, infectious complications, and hypersensitivity in these patients.
Continuing Education
To access the learning assessment and evaluation form online, visit HemNLSer.CME360.net
Statement of Credit—Participants who successfully complete this activity (including scoring at least 70% on the learning assessment and completing and submitting the evaluation form) will be issued a statement of credit via e-mail within 4 weeks.
 Nurses. This activity for 0.9 contact hour is provided by the Meniscus Educational Institute.
|
The Meniscus Educational Institute is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
|
 |
Accreditation refers to recognition of educational activities only and does not imply approval or endorsement by the Meniscus Educational Institute or the American Nurses Credentialing
Center’s Commission on Accreditation of any product mentioned.
Provider approved by the California Board of Registered Nursing, Provider No. 13164, for 0.9 contact hour.
Financial Disclosures
All individuals in positions to control the content of this program (eg, planners, faculty, content reviewers) are expected to disclose all financial relationships with commercial interests that may have a direct bearing on the subject matter of this continuing education activity. Participants have the responsibility to assess the impact (if any) of the disclosed information on the educational value of the activity. All faculty have been offered a modest honorarium from the accredited provider for their participation in this activity.
- Sandra Kurtin, RN, MS, AOCN, ANP-C, Moderator, receives honoraria from Celgene Corporation and Novartis Pharmaceuticals.
- Beth Faiman, MSN, APRN, BC, AOCN, Faculty, receives honoraria from Celgene Corporation and Millennium Pharmaceuticals, Inc.
- Barbara Rogers, CRNP, MN, AOCN, ANP-BC, Faculty, receives honoraria from Celgene Corporation, Cephalon, Inc, Millennium Pharmaceuticals, Inc, and Genentech, Inc.
- Karen Klarkowski, RN, OCN, Pilot Reviewer, has nothing to disclose.
- Pamela Wilson, RN, Pilot Reviewer, has nothing to disclose.
- Jennifer Wulff, MN, ARNP, AOCNP, Pilot Reviewer, has nothing to disclose.
- Karen Abbas, RN, MS, AOCN, Nurse Planner, has nothing to disclose.
Disclaimer
This activity has been designed to provide continuing education that is focused on specific objectives. In selecting educational activities clinicians should pay special attention to the relevance of those objectives and the application to their particular needs. The intent of all Meniscus Educational Institute educational opportunities is to provide learning that will improve patient care. Clinicians are encouraged to reflect on this activity and its applicability to their own patient population.
The opinions expressed in this activity are those of the faculty and reviewers and do not represent an endorsement by MEI of any specific therapeutics or approaches to diagnosis or patient management.
Product Disclosure
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the US Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product.
There is no fee for participating in this activity.
|
The Accreditation Program of the American Nurses Credentialing Center is interested in the opinions and perspectives of the participants in accredited continuing nursing education activities, particularly perspectives related to the presence of perceived bias* in an activity. For this reason, we provide a toll-free telephone number, which participants may call at any time to tell us about
- Any noted bias or conflict of interest in the education
- Any concerns, compliments, or opinions
- A great experience
- An unpleasant experience
- Your thoughts on the process
Just call and tell us!
1-866-262-9730
*Bias is defined as preferential influence that causes a distortion of opinion or facts. Commercial bias may occur when an educational activity promotes one or more product(s) (drugs, devices, services, software, hardware, etc). This definition is not all inclusive, and participants may use their own interpretation in deciding whether a presentation is biased.
NOTE: statements of commercial support and/or conflict of interest disclosures do not represent bias. Such statements inform the learner that the provider has implemented a mechanism to identify and resolve all conflicts of interest prior to delivery of the educational material.
|
Download Activity
Select “Yes” if you have reviewed the CE information above and would like to proceed to download the activity.
Yes
No |
[back to the top]
|
